Geert Labots

545 total citations
13 papers, 273 citations indexed

About

Geert Labots is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Internal Medicine. According to data from OpenAlex, Geert Labots has authored 13 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 6 papers in Economics and Econometrics and 3 papers in Internal Medicine. Recurrent topics in Geert Labots's work include Frailty in Older Adults (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Nutrition and Health in Aging (3 papers). Geert Labots is often cited by papers focused on Frailty in Older Adults (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Nutrition and Health in Aging (3 papers). Geert Labots collaborates with scholars based in Netherlands, Vietnam and United States. Geert Labots's co-authors include Herman M.A. Hofstee, Menno V. Huisman, Wendy Zondag, Laura M. Faber, Aubrey Jones, Jacobus Burggraaf, Robert Rißmann, Saco J. de Visser, Birgitta I. Hiddinga and Marc Durian and has published in prestigious journals such as International Journal of Cancer, European Respiratory Journal and European Journal of Cancer.

In The Last Decade

Geert Labots

11 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geert Labots Netherlands	7	156	111	57	56	35	13	273
Eric Tseng Canada	10	53 0.3×	66 0.6×	26 0.5×	32 0.6×	38 1.1×	28	247
B. Satger France	10	141 0.9×	77 0.7×	13 0.2×	5 0.1×	19 0.5×	31	295
D R Jones United Kingdom	6	75 0.5×	95 0.9×	35 0.6×	15 0.3×	76 2.2×	9	332
Nicolas Chin‐Yee Canada	8	10 0.1×	40 0.4×	34 0.6×	48 0.9×	11 0.3×	15	191
Sajid Haque United States	9	11 0.1×	48 0.4×	53 0.9×	58 1.0×	3 0.1×	15	256
Maki Murakami Japan	9	137 0.9×	56 0.5×	24 0.4×	74 1.3×	1 0.0×	16	352
Aaron L. Troy United States	7	24 0.2×	65 0.6×	20 0.4×	14 0.3×	83 2.4×	14	251
Birgitte Klindt Poulsen Denmark	8	82 0.5×	150 1.4×	14 0.2×	8 0.1×	45 1.3×	18	270
Nicole Solomon United States	9	28 0.2×	65 0.6×	73 1.3×	6 0.1×	15 0.4×	23	338
Regina Dalmau Spain	9	11 0.1×	149 1.3×	25 0.4×	19 0.3×	51 1.5×	36	272

Countries citing papers authored by Geert Labots

Since Specialization

Citations

This map shows the geographic impact of Geert Labots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Labots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Labots more than expected).

Fields of papers citing papers by Geert Labots

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Labots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Labots. The network helps show where Geert Labots may publish in the future.

Co-authorship network of co-authors of Geert Labots

This figure shows the co-authorship network connecting the top 25 collaborators of Geert Labots. A scholar is included among the top collaborators of Geert Labots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert Labots. Geert Labots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Joode, Karlijn de, Ellen Kapiteijn, Marije Slingerland, et al.. (2025). Impact of geriatric impairments on outcomes of single‐agent immunotherapy in solid tumors. International Journal of Cancer. 158(5). 1370–1382.

Joode, Karlijn de, Ellen Kapiteijn, Marije Slingerland, et al.. (2025). Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors. European Journal of Cancer. 225. 115568–115568. 1 indexed citations

Mooijaart, Simon P., Floor J. van Deudekom, Dina Vojinović, et al.. (2024). The performance of metabolomics-based prediction scores for mortality in older patients with solid tumors. GeroScience. 46(6). 5615–5627. 3 indexed citations

Trompet, Stella, Barbara C. Van Munster, Diana van Heemst, et al.. (2024). Association of Glasgow Prognostic Score with frailty, mortality and adverse health outcomes in older patients with cancer: A prospective cohort study. Journal of Geriatric Oncology. 15(8). 102075–102075. 1 indexed citations

Trompet, Stella, Frederiek van den Bos, Diana van Heemst, et al.. (2024). Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study. Drugs & Aging. 41(5). 431–441. 6 indexed citations

Glas, Nienke A. de, Stella Trompet, Geert Labots, et al.. (2023). Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients. JAMA Network Open. 6(10). e2339116–e2339116. 31 indexed citations

Aken, Maarten O. van, Geert Labots, N.E. Kolfschoten, et al.. (2023). Evaluation of an integrated care pathway for out-of-hospital treatment of older adults with an acute moderate-to-severe lower respiratory tract infection or pneumonia: protocol of a mixed methods study. BMJ Open. 13(8). e073126–e073126.

Deudekom, Floor J. van, Stella Trompet, Iris Postmus, et al.. (2021). Design and rationale of a routine clinical care pathway and prospective cohort study in older patients needing intensive treatment. BMC Geriatrics. 21(1). 29–29. 16 indexed citations

Bakker, C. J. G., Jasper van der Aart, Geert Labots, et al.. (2021). Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects. Drugs in R&D. 21(3). 295–304. 5 indexed citations

10.

Labots, Geert, Aubrey Jones, Saco J. de Visser, Robert Rißmann, & Jacobus Burggraaf. (2018). Gender differences in clinical registration trials: is there a real problem?. British Journal of Clinical Pharmacology. 84(4). 700–707. 51 indexed citations

11.

Zondag, Wendy, Marc Durian, Laura M. Faber, et al.. (2013). Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function. Journal of Thrombosis and Haemostasis. 11(4). 686–692. 71 indexed citations

12.

Zondag, Wendy, Birgitta I. Hiddinga, Monique J. T. Crobach, et al.. (2012). Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism. European Respiratory Journal. 41(3). 588–592. 30 indexed citations

13.

Crobach, Monique J. T., Marjolein L. Donker, Michiel Eijsvogel, et al.. (2012). Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thrombosis and Haemostasis. 109(1). 47–52. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact